Dallas, TX (PRWEB) March 20, 2014
The Repair Stem Cells Institute (RSCI) -- http://www.repairstemcells.org -- is pleased to announce that it will assist interested patients to take part in a patient-sponsored research study based in the United States for the treatment of Type2 Diabetes with adult stem cells. The study, which meets current FDA guidelines, will be conducted during April 2014.
The study is being conducted by the U.S. based company Bioheart which has assembled teams of doctors and specialists specially trained in stem cell treatments. Based on previous treatment of Type 2 diabetes with autologous (the patient’s own) stem cells, it is estimated that two-thirds of participants will experience a significant quality of life improvement and symptoms reduction.
Type 2 diabetes makes up about 90% of cases of diabetes. Rates of type 2 diabetes have increased markedly since 1960. Today there are approximately 50 million people suffering from the disease compared to 15 million in 1985.
In a recent interview, RSCI founder and Chairman Don Margolis stated, “With stem cell treatment rapidly coming to the forefront of 21st Century medicine, we are pleased that Type 2 Diabetes is among the many chronic conditions that are treatable with adult stem cells rather than potentially risky surgery, dangerous transplants, and toxic drugs.”
Patients suffering from Type 2 diabetes who are cancer-free can apply to participate.
What will happen?
The 4-part procedure will be done in a participating doctor’s office as a point-of-care out-patient.
1. Adipose Harvest: During a 3 to 5 hour visit to the doctor’s office, a mini-liposuction on your stomach will extract a small amount of tummy fat containing tens of millions of adipose stem cells.
2. Laboratory Processing: The extracted stem cells will be isolated, analyzed, cleaned and concentrated.
3. Stem Cell Implantation: Up to 60 million stem cells will be transplanted intravenously, usually into your arm. Because these are the patient’s own cells, the risk of rejection is non-existent.
4. Postoperative Care: Normally, patients can leave shortly after implantation. RSCI will check on your progress monthly by telephone for the first year after stem cells.
The cost to each participant in the study, including all treatments and follow-up care, is $5,000 The same procedure can be done any time at competent stem cell treatment centers worldwide, but it will cost more, sometimes double.
How to participate
Those interested in participating in this trial should contact the Repair Stem Cell Institute as soon as possible since participation is limited to 100 Type2 Diabetes patients. Those who apply first get their pick of treatment dates.
To date, commercial stem cell treatments have been used by over 40,000 patients with a success rate over 65% for more than 100 debilitating chronic conditions. In addition, over 20,000 patients have been treated in registered clinical trials around the world.
A full list of diseases that stem cells can help can be found on the website of the Repair Stem Cell Institute, often called “The Voice of Stem Cell Science.” RSCI is the world’s only stem cell patients’ advocacy group and is committed to assisting people to make educated choices about their medical conditions and treatments.
For more information about adult stem cells, stem cell treatment, diseases stem cells can help, and the top international stem cell treatment centers, the Repair Stem Cells Institute website offers a wealth of straightforward and unbiased information and solutions.
Repair Stem Cells Institute
3010 LBJ Freeway, Suite 1200
Dallas, TX 75234
Tel: (214) 556-6377